Consolidation nivolumab and ipilimumab versus observation in limited-disease small-cell lung cancer after chemo-radiotherapy - results from the randomised phase II ETOP/IFCT 4-12 STIMULI trial
Auteurs / Authors: S. Peters, J-L. Pujol, U. Dafni, M. Dómine, S. Popat, M. Reck, J. Andrade, A. Becker, D. Moro-Sibilot, A. Curioni-Fontecedro, O. Molinier , K. Nackaerts , A. Insa Mollá, R. Gervais, G. López Vivanco, J. Madelaine, J. Mazieres, M. Faehling, F. Griesinger, M. Majem, J L. González Larriba , M. Provencio Pulla, K. Vervita, H. Roschitzki-Voser, B. Ruepp, P. Mitchell, R A. Stahel, C. Le Pechoux, D. De Ruysscher
Journal / Conference: Annals of Oncology
Année / Year: 2021
PMID: 34562610
Lien vers la publication: https://pubmed.ncbi.nlm.nih.gov/34562610/
